Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Operating Expenses | 15,403 | 6,046 | 5,873 | 5,035 | 6,292 |
| Operating Income | -15,015 | -6,046 | -5,873 | -5,035 | -6,292 |
| Other Income | 79 | 152 | 446 | -148 | -284 |
| Pre-tax Income | -14,936 | -5,894 | -5,427 | -5,183 | -6,576 |
| Net Income Continuous | -14,936 | -5,894 | -5,427 | -5,183 | -6,576 |
| Net Income | $-14,936 | $-5,894 | $-5,427 | $-5,183 | $-6,576 |
| EPS Basic Total Ops | -1.90 | -0.80 | -0.70 | -0.70 | -0.80 |
| EPS Basic Continuous Ops | -1.92 | -0.77 | -0.71 | -0.68 | -0.87 |
| EPS Diluted Total Ops | -1.90 | -0.80 | -0.70 | -0.70 | -0.80 |
| EPS Diluted Continuous Ops | -1.92 | -0.77 | -0.71 | -0.68 | -0.87 |
| EBITDA(a) | $-14,820 | $-5,568 | $-5,399 | $-4,580 | $-5,918 |